Serving leading biopharmaceutical companies globally:

Last Updated: March 29, 2020

DrugPatentWatch Database Preview

BENLYSTA Drug Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: BENLYSTA

Patents:	43
Applicants:	2
BLAs:	2
Recent Clinical Trials:	See clinical trials for BENLYSTA

Recent Clinical Trials for BENLYSTA

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
University of Cambridge	Phase 2
Newcastle University	Phase 2
University of Glasgow	Phase 2

See all BENLYSTA clinical trials

Pharmacology for BENLYSTA

Mechanism of Action	B Lymphocyte Stimulator-directed Antibody Interactions
Physiological Effect	Decreased B Lymphocyte Activation

Patent Text Search: US Patents for BENLYSTA

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Human Genome Sciences Inc.	BENLYSTA	belimumab	INJECTABLE; INJECTION	125370	001	2011-03-09	Start Trial	The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC)	2039-02-26	RX		search
Human Genome Sciences Inc.	BENLYSTA	belimumab	INJECTABLE; INJECTION	125370	001	2011-03-09	Start Trial	CureVac AG (Tubingen, DE)	2032-02-15	RX		search
Human Genome Sciences Inc.	BENLYSTA	belimumab	INJECTABLE; INJECTION	125370	001	2011-03-09	Start Trial	Exagen Diagnostics, Inc. (Vista, CA)	2031-02-11	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for BENLYSTA

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	2015201433	Start Trial
World Intellectual Property Organization (WIPO)	2015103987	Start Trial
Japan	2014505264	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Moodys

Express Scripts

Baxter

Harvard Business School

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.